Eversept Partners, L.P. 13F annual report

Eversept Partners, L.P. is an investment fund managing more than $1.31 trillion ran by Ron Rosenstraus. There are currently 72 companies in Mr. Rosenstraus’s portfolio. The largest investments include GSK Plc and Natera Inc, together worth $261 billion.

Limited to 30 biggest holdings

$1.31 trillion Assets Under Management (AUM)

As of 7th August 2024, Eversept Partners, L.P.’s top holding is 3,468,080 shares of GSK Plc currently worth over $134 billion and making up 10.2% of the portfolio value. Relative to the number of outstanding shares of GSK Plc, Eversept Partners, L.P. owns more than approximately 0.1% of the company. In addition, the fund holds 1,173,494 shares of Natera Inc worth $127 billion, whose value grew 65.4% in the past six months. The third-largest holding is Insmed Inc worth $77.4 billion and the next is Teva Pharmaceutical Inds Ltd worth $76.7 billion, with 4,720,460 shares owned.

Currently, Eversept Partners, L.P.'s portfolio is worth at least $1.31 trillion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Eversept Partners, L.P.

The Eversept Partners, L.P. office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Ron Rosenstraus serves as the Chief Financial Officer at Eversept Partners, L.P..

Recent trades

In the most recent 13F filing, Eversept Partners, L.P. revealed that it had opened a new position in Insmed Inc and bought 1,155,588 shares worth $77.4 billion. This means they effectively own approximately 0.1% of the company. Insmed Inc makes up 8.5% of the fund's Health Care sector allocation and has grown its share price by 242.5% in the past year.

The investment fund also strengthened its position in Syndax Pharmaceuticals Inc by buying 480,518 additional shares. This makes their stake in Syndax Pharmaceuticals Inc total 3,613,631 shares worth $74.2 billion. Syndax Pharmaceuticals Inc soared 5.4% in the past year.

On the other hand, there are companies that Eversept Partners, L.P. is getting rid of from its portfolio. Eversept Partners, L.P. closed its position in Pfizer on 14th August 2024. It sold the previously owned 1,102,042 shares for $30.6 billion. Ron Rosenstraus also disclosed a decreased stake in GSK Plc by approximately 0.1%. This leaves the value of the investment at $134 billion and 3,468,080 shares.

One of the largest hedge funds

The two most similar investment funds to Eversept Partners, L.P. are Jordan Park and Cerity Partners Ocio. They manage $1.31 trillion and $1.31 trillion respectively.


Ron Rosenstraus investment strategy

Eversept Partners, L.P.’s portfolio is diversified across 3 sectors. Currently, their heaviest sector is Health Care — making up 69.7% of the total portfolio value. The fund focuses on investments in the United States as 58.3% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 18% of the total holdings value. On the other hand, small-cap stocks make up only 1.4% of the portfolio. The average market cap of the portfolio companies is close to $13.3 billion.

The complete list of Eversept Partners, L.P. trades based on 13F SEC filings

These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
GSK Plc
8.06%
3,468,080
$133,521,080,000 10.22%
Natera Inc
34.00%
1,173,494
$127,077,665,000 9.73%
Insmed Inc
Opened
1,155,588
$77,424,396,000 5.93%
Teva Pharmaceutical Inds Ltd
21.65%
4,720,460
$76,707,475,000 5.87%
United Therapeutics Corp
6.29%
235,351
$74,971,061,000 5.74%
Syndax Pharmaceuticals Inc
15.34%
3,613,631
$74,187,844,000 5.68%
Vera Therapeutics Inc
12.03%
2,043,214
$73,923,483,000 5.66%
Inspire Med Sys Inc
26.70%
533,011
$71,332,862,000 5.46%
Revvity Inc.
6.54%
451,582
$47,352,889,000 3.62%
HCA Healthcare Inc
30.49%
135,480
$43,527,014,000 3.33%
Bio-Techne Corp
10.64%
543,044
$38,909,103,000 2.98%
Healthequity Inc
1.85%
413,531
$35,646,372,000 2.73%
Pfizer Inc.
Closed
1,102,042
$30,581,666,000
Community Health Sys Inc New
0.71%
8,037,470
$27,005,899,000 2.07%
Shockwave Med Inc
Closed
80,555
$26,231,125,000
Repligen Corp.
2,258.76%
194,291
$24,492,323,000 1.87%
Celldex Therapeutics Inc.
10.98%
633,015
$23,427,885,000 1.79%
Ionis Pharmaceuticals Inc
21.37%
456,881
$21,774,948,000 1.67%
Novo-nordisk A S
135.72%
146,956
$20,976,499,000 1.61%
Eli Lilly Co
64.89%
21,233
$19,223,934,000 1.47%
Tenet Healthcare Corp.
Closed
175,631
$18,460,574,000
Protagonist Therapeutics Inc
22.93%
505,836
$17,527,217,000 1.34%
Argenx Se
36.55%
34,593
$14,876,374,000 1.14%
Humana Inc.
7.01%
38,023
$14,207,294,000 1.09%
Viatris Inc.
0.97%
1,329,282
$14,130,268,000 1.08%
Zimvie Inc
35.99%
767,659
$14,009,777,000 1.07%
Mannkind Corp
5.61%
2,256,952
$11,781,289,000 0.90%
Taro Pharmaceutical Inds Ltd
Closed
263,541
$11,158,326,000
Brookdale Sr Living Inc
17.29%
1,546,842
$10,564,931,000 0.81%
Danaher Corp.
No change
40,855
$10,207,622,000 0.78%
Spdr Ser Tr
Opened
100,000
$9,271,000,000 0.71%
Travere Therapeutics Inc
14.18%
1,091,165
$8,969,376,000 0.69%
Elevance Health Inc
1.83%
14,657
$7,942,042,000 0.61%
Arcutis Biotherapeutics Inc
Opened
837,847
$7,791,977,000 0.60%
Centene Corp.
24.82%
115,820
$7,678,866,000 0.59%
Viridian Therapeutics Inc
299.43%
567,487
$7,383,006,000 0.57%
Viking Therapeutics Inc
506.93%
138,489
$7,341,302,000 0.56%
Vaxcyte, Inc.
51.31%
96,089
$7,255,680,000 0.56%
Biocryst Pharmaceuticals Inc.
19.54%
1,152,573
$7,122,901,000 0.55%
Cytokinetics Inc
Opened
126,877
$6,874,196,000 0.53%
Taysha Gene Therapies, Inc.
Closed
2,325,591
$6,674,446,000
Newamsterdam Pharma Company
6.80%
329,890
$6,337,187,000 0.48%
Evolus Inc
Opened
574,462
$6,232,913,000 0.48%
Molina Healthcare Inc
213.61%
18,277
$5,433,752,000 0.42%
Sutro Biopharma Inc
59.35%
1,739,129
$5,095,648,000 0.39%
Gossamer Bio, Inc.
8.51%
5,484,148
$4,940,669,000 0.38%
Oscar Health, Inc.
Opened
310,893
$4,918,327,000 0.38%
Waters Corp.
Closed
13,628
$4,691,166,000
Cerevel Therapeutics Hldng I
Opened
110,010
$4,498,309,000 0.34%
Liquidia Corp
5.71%
373,554
$4,482,648,000 0.34%
Myriad Genetics, Inc.
Opened
181,961
$4,450,766,000 0.34%
Puma Biotechnology Inc
6.87%
1,328,454
$4,330,760,000 0.33%
Karyopharm Therapeutics Inc
0.58%
4,987,180
$4,326,877,000 0.33%
2seventy Bio Inc
5.94%
1,107,743
$4,264,811,000 0.33%
Nevro Corp
28.16%
499,395
$4,204,906,000 0.32%
Icon Plc
17.63%
12,642
$3,962,888,000 0.30%
Merus N.V
44.36%
66,474
$3,933,267,000 0.30%
Corbus Pharmaceuticals Hldgs
Closed
88,934
$3,489,770,000
Krystal Biotech Inc
Closed
18,557
$3,301,847,000
Moonlake Immunotherapeutics
Opened
71,596
$3,148,076,000 0.24%
Morphosys AG
Closed
165,924
$3,009,861,000
Amarin Corp Plc
30.65%
4,308,527
$2,964,267,000 0.23%
Guardant Health Inc
77.90%
99,377
$2,870,008,000 0.22%
Inflarx Nv
20.06%
1,566,930
$2,726,458,000 0.21%
Avantor, Inc.
No change
125,394
$2,658,353,000 0.20%
Tourmaline Bio Inc
Opened
204,781
$2,633,484,000 0.20%
IQVIA Holdings Inc
No change
12,178
$2,574,916,000 0.20%
Alector, Inc.
1.04%
541,739
$2,459,495,000 0.19%
Immunovant Inc
63.64%
92,909
$2,452,798,000 0.19%
Xoma Corp Del
5.31%
91,907
$2,177,277,000 0.17%
Autolus Therapeutics plc
Opened
610,902
$2,125,939,000 0.16%
Terns Pharmaceuticals Inc
1.14%
286,266
$1,949,471,000 0.15%
Mereo BioPharma Group plc
Opened
496,171
$1,786,216,000 0.14%
Aerovate Therapeutics Inc
Closed
54,150
$1,601,216,000
Curevac N V
Closed
515,691
$1,562,544,000
Kura Oncology Inc
Opened
72,317
$1,489,007,000 0.11%
Absci Corporation
Opened
325,509
$1,002,568,000 0.08%
Fulcrum Therapeutics Inc
Opened
152,965
$948,383,000 0.07%
Affimed N.V.
No change
166,460
$907,207,000 0.07%
Stoke Therapeutics, Inc.
78.87%
61,277
$827,852,000 0.06%
G1 Therapeutics Inc
Opened
199,963
$455,916,000 0.03%
Vincerx Pharma Inc
Closed
79,588
$402,715,000
AC Immune SA
20.29%
99,313
$396,259,000 0.03%
Seres Therapeutics Inc
69.89%
418,208
$302,699,000 0.02%
No transactions found
Showing first 500 out of 84 holdings